Mervyn Tyrer

1.0k total citations
27 papers, 820 citations indexed

About

Mervyn Tyrer is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mervyn Tyrer has authored 27 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 24 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in Mervyn Tyrer's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (17 papers). Mervyn Tyrer is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (17 papers). Mervyn Tyrer collaborates with scholars based in United Kingdom, Qatar and United States. Mervyn Tyrer's co-authors include Andrew Phillips, Clive Loveday, Caroline Sabin, Amanda Mocroft, Margaret Johnson, Marc Lipman, Sara Madge, Antonia L. Moore, Clinton Chaloner and M Youle and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and AIDS.

In The Last Decade

Mervyn Tyrer

27 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mervyn Tyrer United Kingdom 15 668 496 227 143 72 27 820
Antonia L. Moore United Kingdom 11 537 0.8× 362 0.7× 166 0.7× 244 1.7× 33 0.5× 17 742
P. de Truchis France 10 351 0.5× 251 0.5× 201 0.9× 147 1.0× 22 0.3× 20 589
Barbara Bastow United States 12 405 0.6× 359 0.7× 160 0.7× 171 1.2× 86 1.2× 19 602
Catherine Dhiver France 8 307 0.5× 252 0.5× 116 0.5× 135 0.9× 48 0.7× 10 570
Li Ts China 7 305 0.5× 350 0.7× 221 1.0× 58 0.4× 37 0.5× 19 598
Jane R Deayton United Kingdom 9 190 0.3× 260 0.5× 382 1.7× 74 0.5× 22 0.3× 17 510
Laurie Myers United States 8 656 1.0× 454 0.9× 123 0.5× 533 3.7× 25 0.3× 8 899
Monica Guffanti Italy 11 206 0.3× 143 0.3× 82 0.4× 158 1.1× 22 0.3× 28 349
Osvalda Rampon Italy 14 292 0.4× 306 0.6× 151 0.7× 134 0.9× 11 0.2× 30 573
Frederikke F. Rönsholt Denmark 10 156 0.2× 123 0.2× 134 0.6× 166 1.2× 58 0.8× 24 411

Countries citing papers authored by Mervyn Tyrer

Since Specialization
Citations

This map shows the geographic impact of Mervyn Tyrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mervyn Tyrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mervyn Tyrer more than expected).

Fields of papers citing papers by Mervyn Tyrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mervyn Tyrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mervyn Tyrer. The network helps show where Mervyn Tyrer may publish in the future.

Co-authorship network of co-authors of Mervyn Tyrer

This figure shows the co-authorship network connecting the top 25 collaborators of Mervyn Tyrer. A scholar is included among the top collaborators of Mervyn Tyrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mervyn Tyrer. Mervyn Tyrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lodwick, Rebecca, Sherry Johnson, Colette Smith, et al.. (2012). Effect of patient smoking status on CD4 count change after initiation of antiretroviral therapy. UCL Discovery (University College London). 1 indexed citations
2.
Tyrer, Mervyn, et al.. (2010). Switching to dual therapy with darunavir/ritonavir and etravirine: a simplification strategy. Journal of the International AIDS Society. 13(S4). 1 indexed citations
3.
Lodwick, Rebecca, Colette Smith, Mike Youle, et al.. (2008). Stability of antiretroviral regimens in patients with viral suppression. AIDS. 22(9). 1039–1046. 32 indexed citations
4.
Smith, Colette, AN Phillips, MA Johnson, et al.. (2008). Factors associated with viral rebound among highly treatment‐experienced HIV‐positive patients who have achieved viral suppression. HIV Medicine. 10(1). 19–27. 20 indexed citations
5.
Booth, Clare, et al.. (2008). Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism. Journal of Antimicrobial Chemotherapy. 62(6). 1188–1190. 2 indexed citations
6.
7.
Smith, Colette, Caroline Sabin, Fiona Lampe, et al.. (2005). The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimens.. PubMed. 10(3). 459–67. 13 indexed citations
8.
Youle, Mike, Mervyn Tyrer, Martin Fisher, et al.. (2002). Two-Year Outcome of a Multidrug Regimen in Patients Who Did Not Respond to a Protease Inhibitor Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(1). 58–61. 14 indexed citations
9.
Moore, Antonia L., Mike Youle, Marc Lipman, et al.. (2002). Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?. AIDS. 16(4). 615–618. 37 indexed citations
10.
Youle, Mike, Mervyn Tyrer, Martin Fisher, et al.. (2002). Two-Year Outcome of a Multidrug Regimen in Patients Who Did Not Respond to a Protease Inhibitor Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(1). 58–61. 11 indexed citations
11.
Allen, Susan Hannah, Antonia L. Moore, Mervyn Tyrer, B. Holloway, & Margaret Johnson. (2002). Osteonecrosis of the knee in a patient receiving antiretroviral therapy. International Journal of STD & AIDS. 13(11). 792–794. 7 indexed citations
12.
Mocroft, Amanda, M Youle, Antonia L. Moore, et al.. (2001). Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS. 15(2). 185–194. 189 indexed citations
13.
Jolles, Stephen, Mervyn Tyrer, Monica M. Johnson, & D Webster. (2001). Long term recovery of IgG and IgM production during HIV infection in a patient with common variable immunodeficiency (CVID). Journal of Clinical Pathology. 54(9). 713–715. 27 indexed citations
14.
Youle, Mike, G Jánossy, Clive Loveday, et al.. (2000). Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens. AIDS. 14(12). 1717–1720. 33 indexed citations
15.
Madge, Sara, Amanda Mocroft, Darren Wilson, et al.. (2000). Participation in clinical studies among patients infected with HIV‐1 in a single treatment centre over 12 years. HIV Medicine. 1(4). 212–218. 24 indexed citations
16.
Devereux, Helen, Sabine Kinloch-de-Loës, Mervyn Tyrer, et al.. (2000). Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. AIDS. 14(11). 1545–1552. 80 indexed citations
17.
Mocroft, Amanda, Caroline Sabin, M Youle, et al.. (1999). Changing treatment patterns among patients with HIV: Royal Free Hospital 1987–97. HIV Medicine. 1(1). 32–39. 11 indexed citations
18.
Mocroft, Amanda, Caroline Sabin, M Youle, et al.. (1999). Changes in AIDS-Defining Illnesses in a London Clinic, 1987–1998. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 21(5). 401–401. 26 indexed citations
19.
Phillips, Andrew, Angela R. McLean, Clive Loveday, et al.. (1999). In vivo HIV-1 replicative capacity in early and advanced infection. AIDS. 13(1). 67–73. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonia L. Moore Breakdown of academic impact, for papers by P. de Truchis Breakdown of academic impact, for papers by Barbara Bastow Breakdown of academic impact, for papers by Catherine Dhiver Breakdown of academic impact, for papers by Li Ts Breakdown of academic impact, for papers by Jane R Deayton Breakdown of academic impact, for papers by Laurie Myers Breakdown of academic impact, for papers by Monica Guffanti Breakdown of academic impact, for papers by Osvalda Rampon Breakdown of academic impact, for papers by Frederikke F. Rönsholt
Rankless by CCL
2026